[go: up one dir, main page]

NO20024480D0 - Lipopolysakkarider fra Escherichia coli - Google Patents

Lipopolysakkarider fra Escherichia coli

Info

Publication number
NO20024480D0
NO20024480D0 NO20024480A NO20024480A NO20024480D0 NO 20024480 D0 NO20024480 D0 NO 20024480D0 NO 20024480 A NO20024480 A NO 20024480A NO 20024480 A NO20024480 A NO 20024480A NO 20024480 D0 NO20024480 D0 NO 20024480D0
Authority
NO
Norway
Prior art keywords
lipopolysaccharides
escherichia coli
escherichia
coli
Prior art date
Application number
NO20024480A
Other languages
English (en)
Other versions
NO20024480L (no
Inventor
Hans Proppert
Juergen Malinka
Juergen Schulze
Ulrich Sonnenborn
Ulrich Zaehringer
Artur Ulmer
Ernst Theodor Rietschel
Original Assignee
Pharma Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh filed Critical Pharma Zentrale Gmbh
Publication of NO20024480D0 publication Critical patent/NO20024480D0/no
Publication of NO20024480L publication Critical patent/NO20024480L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024480A 2000-03-20 2002-09-19 Lipopolysakkarider fra Escherichia coli NO20024480L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10013539A DE10013539B4 (de) 2000-03-20 2000-03-20 Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen
PCT/EP2001/003153 WO2001070756A2 (de) 2000-03-20 2001-03-20 Lipopolysaccharide aus escherichia coli

Publications (2)

Publication Number Publication Date
NO20024480D0 true NO20024480D0 (no) 2002-09-19
NO20024480L NO20024480L (no) 2002-11-20

Family

ID=7635468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024480A NO20024480L (no) 2000-03-20 2002-09-19 Lipopolysakkarider fra Escherichia coli

Country Status (28)

Country Link
US (1) US6833451B2 (no)
EP (1) EP1266023A2 (no)
JP (1) JP2003528175A (no)
KR (1) KR20030047878A (no)
CN (1) CN1436245A (no)
AP (1) AP2002002622A0 (no)
AU (2) AU2001273899B2 (no)
BG (1) BG107115A (no)
BR (1) BR0109392A (no)
CA (1) CA2402544A1 (no)
CZ (1) CZ20023469A3 (no)
DE (1) DE10013539B4 (no)
EA (1) EA005217B1 (no)
EE (1) EE200200537A (no)
HK (1) HK1053148A1 (no)
HR (1) HRP20020682A2 (no)
HU (1) HUP0204540A3 (no)
IL (1) IL151785A0 (no)
IS (1) IS6517A (no)
MX (1) MXPA02009215A (no)
NO (1) NO20024480L (no)
NZ (1) NZ520968A (no)
PL (1) PL368447A1 (no)
SK (1) SK13492002A3 (no)
UA (1) UA75068C2 (no)
WO (1) WO2001070756A2 (no)
YU (1) YU71202A (no)
ZA (1) ZA200207408B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030031684A1 (en) 2001-03-30 2003-02-13 Corixa Corporation Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
DE10328669B4 (de) * 2003-06-26 2005-12-01 Pharma-Zentrale Gmbh Plasmidfreier Klon des E. coli Stammes DSM 6601
WO2005051321A2 (en) * 2003-11-25 2005-06-09 Washington University Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase
US20050238651A1 (en) * 2003-11-25 2005-10-27 Gurtner Gregory J Treatment of inflammatory bowel disease
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN100354428C (zh) * 2005-01-13 2007-12-12 丁友玲 隧道式干热灭菌设备测试用内毒素指示剂的制备方法
EP1961823B1 (en) 2005-11-28 2024-06-12 Biomedical Research Group Inc. Method for producing lipopolysaccharide and lipopolysaccharide
US9664677B2 (en) 2010-04-19 2017-05-30 Massachusetts Institute Of Technology Polymer-nanostructure composition for selective molecular recognition
US20130066064A1 (en) * 2010-05-20 2013-03-14 Glaxosmithkline Biologicals S.A, Novel process
CN105137073A (zh) * 2015-08-06 2015-12-09 中国兽医药品监察所 牛布鲁氏菌胶体金抗体检测试纸条
PL432842A1 (pl) * 2020-02-10 2021-08-16 Uniwersytet Warszawski LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE
AU2021235152B2 (en) * 2020-03-13 2026-02-05 Hephaistos-Pharma Detoxified lipopolysaccharides (IPS), naturally non-toxic lps, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19844191A1 (de) * 1998-09-28 2000-03-30 Pharma Zentrale Gmbh Lipopolysaccharide aus Escherichia coli

Also Published As

Publication number Publication date
BG107115A (bg) 2003-05-30
ZA200207408B (en) 2003-01-02
EA005217B1 (ru) 2004-12-30
CA2402544A1 (en) 2002-09-10
AP2002002622A0 (en) 2002-09-30
HUP0204540A3 (en) 2003-12-29
CZ20023469A3 (cs) 2003-04-16
NO20024480L (no) 2002-11-20
WO2001070756A3 (de) 2002-05-02
HK1053148A1 (zh) 2003-10-10
HRP20020682A2 (en) 2004-12-31
US6833451B2 (en) 2004-12-21
EE200200537A (et) 2004-04-15
NZ520968A (en) 2005-07-29
AU7389901A (en) 2001-10-03
HUP0204540A2 (hu) 2003-04-28
US20030108573A1 (en) 2003-06-12
JP2003528175A (ja) 2003-09-24
MXPA02009215A (es) 2004-09-10
YU71202A (sh) 2006-01-16
SK13492002A3 (sk) 2003-03-04
DE10013539A1 (de) 2001-10-18
WO2001070756A2 (de) 2001-09-27
KR20030047878A (ko) 2003-06-18
AU2001273899B2 (en) 2005-10-06
EA200200997A1 (ru) 2003-04-24
EP1266023A2 (de) 2002-12-18
PL368447A1 (en) 2005-03-21
CN1436245A (zh) 2003-08-13
UA75068C2 (en) 2006-03-15
DE10013539B4 (de) 2006-07-13
BR0109392A (pt) 2003-06-03
IL151785A0 (en) 2003-04-10
IS6517A (is) 2002-08-21

Similar Documents

Publication Publication Date Title
DE60135560D1 (de) Valsartan salze
DK1671949T3 (da) Substituerede pyridinylaminer
DE60204196D1 (de) Endoskopisches System
DE60037275D1 (de) Geschlechtsbestimmung
DE60105471D1 (de) Videoskop
DE50206892D1 (de) Substituierte imidazotriazinone
DE60236741D1 (de) Schiebevorrichtung
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
NO20024480L (no) Lipopolysakkarider fra Escherichia coli
DE50212108D1 (de) Substituierte fluoralkoxyphenylsulfonylharnstoffe
ATE369745T1 (de) Herbizide zusammensetzung
DE60206716D1 (de) Schlauch
DK1406858T3 (da) Substituerede 4-aminocyklohexanoler
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
DE50200533D1 (de) Beatmungstubus
FR2820817B1 (fr) Projectile
DE50202045D1 (de) Leitungsanordnung
NO20011947L (no) Fiskeredskap
DE60216967D1 (de) Substituierte cyclohexanderivate
DE50214478D1 (de) Aufhänger
DE10295574D2 (de) Geräusch-gesteuertes Beatmungsgerät
UA5875S (uk) Жниварка валкова навісна жвн-6б
FIU20010061U0 (fi) Sisäpostilaatikko
ITBO20010016U1 (it) Evaquatore di fumi
ATA14612001A (de) Portioniervorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application